# Introduction ilson's Disease (WD) is a metabolic disorder resulting from biallelic mutations in the ATP7B gene on chromosome 13 1,2,3 of autosomal recessive inheritance 3 , characterized by the toxic accumulation of this element in the liver, córnea, and central nervous system 4 . The incidence of these mutations in newborns was estimated at 1:7,000 in Sardinia, Italy 5 and 1.7:100,000 in the Republic of Ireland 6 , in contrast, the prevalence of the disease has been estimated to be between 1:250,000 and 1:300,000 in Sweden and between 1:30,000 and 1:40,000 in other populations 7 . Copper is an essential cofactor for several enzymes 8 and is present in foodstuffs such as seafood, pulses, and nuts 9 . Its metabolism is dependent on the ATP7B gene, which is responsible for encoding ceruloplasmin, and on the ATPase, which incorporates it into the bile and allows its exteriorization with the feces 10,11 . Due to the absence of these mechanisms, copper accumulates in the liver until it spills over into the bloodstream. High levels of cupremia cause disruption of the blood-brain barrier and deposition with a cytotoxic effect in the striatum, globus pallidus, locus coeruleus, substantia nigra, and cerebral cortex 4,12 . # II. # Case Report A 31-year-old male, mixed race, bricklayer, residing in Paraisópolis, Minas Gerais State, Brazil. History of alcoholism and drug use. Diagnosis of previous unspecified mood disorder and using Fluoxetine 40mg/day. No other relevant environmental exposures were reported. Report of a male adult family member diagnosed with liver failure of unknown etiology. Magnetic Resonance Imaging (MRI) of the brain on December 1st, 2021, showed involvement of the putamen, associated with hemosiderin residue, and crus posterius bilaterally, in addition to the midbrain and pons, without restriction to diffusion (images 1A-1D), and an extra-axial parietal left paramedian contrastenhanced lesion suggestive of meningioma (images 1E-1F). On December 3rd, 2021, the patient suffered the first generalized clonic tonic seizure while sleeping, and in a follow-up visit on December 21st, he started to use Levetiracetam orally. He was diagnosed with Covid 19 on February 3rd, 2022, with a mild evolution without the need for ventilatory support or complications. The wife noted that the development of the disease was accentuated after the infection. From February 9th, he appeared to have speech and gait disturbance, difficulty mobilizing the right hand, and urinary incontinence. During outpatient follow-up, a new MRI of the brain was requested on April 1st, 2022, which denoted better characterization of foci of signal alteration in cerebellar peduncles (images 2). On June 2022, he had moderate dysarthria, hypomimia, right-hand flexor dystonia, tetraparesis, bradykinesia, and postural instability, but without rigid or resting tremors. The specific treatment was started on May 2022 with pyridoxine chlorhydrate 50 mg daily and zinc sulfate heptahydrate 4 mg/mL 15mL three times a day orally. Due to the cost of the drug, the patient delayed starting penicillamine. # III. # Discussion Incipient neurological symptoms are subtle and nonspecific, such as difficulty concentrating and motor coordination and handwriting changes (for example, micrograph) [13][14][15][16][17][18][19] and begin on average between 20 and 40 years [20][21][22] . As it progresses, more prominent symptoms appear, whose order of incidence is dysarthria (57.6%), dystonia (42.4%), abnormal gait (37.8%), tremor (36.2%), parkinsonism (17.3%), choreoathetosis (15.3%) and convulsion (4.7%) 16,17 . Neurological impairment occurs about a decade after liver failure and, therefore, signs of advanced disease 23 . Cognitive impairment is considered rare and was reported by Machado, Chien, Deguti, et al. ( 2006) 16 in 4.2% of cases. Given the heterogeneity of clinical manifestations, the neurological phenotype of WD can be grouped for didactic purposes into dystonic, pseudosclerotic, parkinsonian, and hyperkinetic subtypes 4 . The patient discussed in this study had a predominance of the dystonic subtype manifested by multifocal dystonia affecting both the risorius muscle (sardonic laughter) and the flexor muscles of the right hand fingers. As reported by Lorincz (2010) 24 , bilateral putaminal lesions were found on an MRI of the brain. Dysarthria can result from any condition that damages the motor control structures necessary for speech production, such as cranial nerves IX, X, XII, cerebellum, and basal ganglia 12 . In this case, it was noted evident bilateral impairment of the basal ganglia. Seizures are not uncommon and are reported variably in 4.7% 16,17 to 14.5% 25 of WD cases. The patient in question presented, at the initial manifestation, a single episode of generalized tonic-clonic seizure without recurrence. We also detected the presence of brownish Kayser Fleischer rings, more evident in the lower region of the iris bilaterally. Such a semiological sign is due to copper deposition in the Descemet's membrane of the cornea 26 and is present in approximately 100% of neuropsychiatric WD cases 10 . Psychiatric symptoms are reported by about 30% to 60% of individuals affected by WD 26 . In this case, the disorder for which the patient had been using Fluoxetine was not specified. However, the familiar states that at the time of initiation of therapy, he had a depressive mood, anhedonia, and anxiety. It is possible that such symptoms were already an incipient manifestation of central nervous system involvement. Cognitive impairment is initially mild and recognized only by family members. It is categorized into frontal lobe syndrome, which involves impulsivity, promiscuity, apathy, hypotenacity, impaired social judgment, planning dysfunction, and emotional lability, and subcortical dementia characterized by slowed thinking amnesia, and executive dysfunction, but without aphasia, apraxia, or agnosia 10 . In this case, it was impossible to attribute a clinical syndrome related to the metabolic disorder, given the history of alcoholism and use of narcotics. IV. # Conclusion This case report represents the importance of a detailed neurological clinical evaluation and the association of findings with Imaging and laboratory workup. It is a rare disease whose epidemiology in Brazil lacks data, and complementary tests have reduced specificity. ![On February 16th, he attended the consultation with the responsible physician who, associated the symptoms with the anticonvulsant and switched to Phenytoin 100mg twice a day and associated Dexamethasone orally. It evolved five days later with intermittent hiccups and prostration that lasted approximately three days.Cerebrospinal fluid (CSF) collected On March 21st revealed a cell count of 0 unit; glucose 89 mg/dL, lactate 15.7 mg/dL, gram without staining bactéria, and CSF culture without bacterial growth.He was hospitalized on March 24th for social reasons to collect WD screening tests. The patient presented to the neurological examination with regular general condition, good spatial orientation, alertness, Glasgow Coma Scale 15, hypomimia, cranial nerve pairs exam without abnormalities, isochoric pupils, normal extrinsic ocular motricity, risus sardonicus, deep tendon reflexes 2/2, muscle strength 5/5 in all testable upper and lower limb muscle groups, somaesthesia, right-hand flexor dystonia, and ataxic gait. Upon slit lamp examination, the presence of Kayser-Fleischer rings was noted.Laboratory workup of March 24th revealed aminotransferase (AST) 37 mg/dL, alanine aminotransferase (ALT) 35 mg/dL, total bilirubin test 1,00 mg/dL, albumin test 3,7 mg/dL, international normalized ratio (INR) 1,17, and platelets 88x10 9 /L. Tests for disorders of Copper metabolism of the same date revealed total serum copper 24,6 mg/dL (reference range (RR) 70mg/dL-150mg/dL), serum ceruloplasmin 7,0 mg/dL (RR 20mg/dL-60mg/dL) and, finally, 24hours urine copper test 187,4 mg/dL (RR 70mg/dL-150mg/dL). Child-Pugh, Fibrosis-4, and APRI scores were, respectively, 5 points (Child Class A -least severe liver disease); 1,99 (undetermined), and 1,11 (significant fibrosis most likely, cirrhosis undetermined). Abdominal ultrasound exam of April 8th, 2022, indicates chronic liver disease with signs of portal hypertension, splenomegaly, and moderate ascites. Electroneuromyography of March 14th, 2022, was absent abnormalities.](image-2.png "W") ![](image-3.png "") ## Disclosure statement No potential conflict of interest was reported by the authors. * The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene PCBull GRTomás JMRommens JRForbes DWCox Nat. Genet 5 1993 * The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene RETanzi KPetrukhin EChernov JLPellequer WWasco BRoss Nat. Genet 5 1993 * The psychopharmacology of Wilson disease and other metabolic disorders. Handbook of clinical neurology MFaoucher CarolineD 2019 165 * Wilson's disease: A master of disguise PHedera Parkinsonism & Related Disorders 59 2019 * Molecular characterization of Wilson disease in the Sardinian population-evidence of a founder effect GLoudianos VDessi MLovicu AAngius AFigus FLilliu Hum. Mutat 14 1999 * An epidemiological study of Wilson's disease in the Republic of Ireland MReilly LDaly MHutchinson Neurosurgery & Psychiatry 56 3 1993 Journal of Neurology * Determination of the frequencies of ten allelic variants of the Wilson disease gene (ATP7B), in pooled DNA samples COlsson EWaldenström KWestermark ULandegre ACSyvanen Eur. J. Hum. Genet 8 2000 * Mielopathy related to copper deficiency after bariatric surgery: case report Mielopatia relacionada à deficiência de cobre após cirurgia bariátrica: relato de caso LalLopes SemSouza VmaFilho MafBorges Brazilian Journal of Health Review 4 6 2021 * American association for study of liver diseases (AASLD) EARoberts MLSchilsky Hepatology 47 2008 Diagnosis and treatment of Wilson's disease: an update * Wilson disease and related copper disorders MTLorincz Handbook of Clinical Neurology 147 2018 * Doença de Menkes: relato de um caso raro na Amazônia IgaTussolini GRTussolini JFTussolini LSPontes MtrJunior PDSilva Brazilian Journal of Health Review 6 1 2023 * Neurological Manifestations of Wilson's Disease: Pathophysiology and Localization of Each Component JFOrtiz AMCox WTambo NEskander MWirth MValdez Cureus 12 11 11509 2020 * Wilson's disease. The presenting symptoms JMWalshe Arch. Dis. Child 37 1962 * Presenting symptoms and natural history of Wilson disease TSaito Eur. J. Pediatr 146 1987 * Neurological and neuropsychiatric spectrum of Wilson's disease: a prospective study of 45 cases WOder GGrimm HKollegger PFerenci BSchneider LDeecke J. Neurol 238 1991 * Neurological manifestations in Wilson's disease: report of 119 cases AMachado HFChien MMDeguti ECançado RSAzevedo MScaff Mov. Disord 21 2006 * Prognostic significance of neurologic examination findings in Wilson disease JFBurke PDayalu NanBAskari FBrewer GJLorincz MT Park. Relat. Disord 17 2011 * Characteristics of a newly diagnosed Polish cohort of patients with neurological manifestations of Wilson disease evaluated with the Unified Wilson's Disease Rating Scale ACz?onkowska TLitwin KDzie?yc MKarli?ski JBring CBjartmar BMC Neurol 18 34 2018 * Clinical assessment of 31 patients with Wilson's disease. Correlations with structural changes on magnetic resonance imaging SSRubinstein ABYoung KKluin GHill AMAisen TGabrielsen Arch. Neurol 44 1987 * Screening for Wilson's disease in patients with liver diseases by serum ceruloplasmin ECauza TMDobersberger CPolli KKaserer LKramer PFerenci J. Hepatol 27 1997 * Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis XXu SPin MGathinji RFuchs ZLHarris Ann. N. Y. Acad. Sci 1012 2004 * An overview and update of ATP7A mutations leading to Menkes disease and occipital horn syndrome ZTümer Hum. Mutat 34 2013 * Pathophysiology and clinical features of Wilson disease PFerenci Metabolic brain disease 19 2004 * Neurologic Wilson's disease MTLorincz Ann N Y Acad Sci 2010. 1184 * Spectrum of epilepsy in Wilson's disease with electroencephalographic, MR imaging and pathological correlates LKPrashanth SSinha ABTaly AMahadevan MKVasudev SKShankar J Neurol Sci 291 2010 * Clinical features of Wilson disease WStremmel UMerle RWeiskirchen Annals of Translational Medicine 7 2 61 2019